Cargando…

Cardiopulmonary dysfunction in perinatally HIV‐infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort

INTRODUCTION: Antiretroviral therapy (ART) has reduced morbidity and mortality in sub‐Saharan Africa, but the burden of coexistent cardiopulmonary disease in perinatally HIV‐positive adolescents on antiretroviral therapy (ART) has not been well described. The aim of this study was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Githinji, Leah N, Mahtab, Sana, Zühlke, Liesl, Lawrenson, John, Myer, Landon, Gray, Diane, Zar, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619484/
https://www.ncbi.nlm.nih.gov/pubmed/31291058
http://dx.doi.org/10.1002/jia2.25340
_version_ 1783433939165118464
author Githinji, Leah N
Mahtab, Sana
Zühlke, Liesl
Lawrenson, John
Myer, Landon
Gray, Diane
Zar, Heather
author_facet Githinji, Leah N
Mahtab, Sana
Zühlke, Liesl
Lawrenson, John
Myer, Landon
Gray, Diane
Zar, Heather
author_sort Githinji, Leah N
collection PubMed
description INTRODUCTION: Antiretroviral therapy (ART) has reduced morbidity and mortality in sub‐Saharan Africa, but the burden of coexistent cardiopulmonary disease in perinatally HIV‐positive adolescents on antiretroviral therapy (ART) has not been well described. The aim of this study was to investigate the prevalence and associations of cardiopulmonary dysfunction in adolescents with perinatally acquired HIV on ART. METHODS: For this cross‐sectional analysis, 515 perinatally HIV‐positive adolescents ages 9 to 14 years on ART for at least six months, and a comparator group of 110 age‐matched HIV‐uninfected adolescents were tested between August 2013 and April 2015 using echocardiography, six‐minute walk test (6MWT) and spirometry. Those with either abnormal spirometry or abnormal 6MWT and any right or left systolic or diastolic dysfunction or abnormal mean pulmonary arterial pressure were considered as having impaired cardiopulmonary function. Logistic regression was used to investigate determinants of impaired cardiopulmonary function. RESULTS: Overall, 474 adolescents with perinatally acquired HIV (mean [SD] age, 12 [1.6] years; median [IQR] ART duration, 7 [4.6 to 9.3] years; median [IQR] CD4 count, 712 [571 to 959] cell/mm(3)) and 109 HIV‐uninfected adolescents mean (SD) age 11.8 (1.8) years, had successful cardiac and lung function testing. Impaired cardiopulmonary function was detected in 13% of adolescents with perinatally acquired HIV and 8% of HIV‐uninfected adolescents, p = 0.136. Among adolescents with perinatally acquired HIV, those with low tricuspid annular plane systolic excursion (TAPSE) had significantly lower mean FEV(1), 1.5 L versus 1.6 L, p = 0.011. Height (OR 0.7, 95%CI 0.5 to 0.9), body mass index (OR 0.7, 95%CI 0.5 to 0.9) and past pulmonary tuberculosis (OR 2.3, 95%CI 1.2 to 4.4) were significantly associated with a low cardiopulmonary function. CONCLUSIONS: Despite being on ART, cardiopulmonary dysfunction occurs in an appreciable proportion of perinatally HIV‐infected adolescents but no significant difference to uninfected controls. This finding requires further exploration. Factors associated with dysfunction may be amenable to public health interventions to reduce cardiopulmonary disease in this population.
format Online
Article
Text
id pubmed-6619484
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66194842019-07-16 Cardiopulmonary dysfunction in perinatally HIV‐infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort Githinji, Leah N Mahtab, Sana Zühlke, Liesl Lawrenson, John Myer, Landon Gray, Diane Zar, Heather J Int AIDS Soc Research Articles INTRODUCTION: Antiretroviral therapy (ART) has reduced morbidity and mortality in sub‐Saharan Africa, but the burden of coexistent cardiopulmonary disease in perinatally HIV‐positive adolescents on antiretroviral therapy (ART) has not been well described. The aim of this study was to investigate the prevalence and associations of cardiopulmonary dysfunction in adolescents with perinatally acquired HIV on ART. METHODS: For this cross‐sectional analysis, 515 perinatally HIV‐positive adolescents ages 9 to 14 years on ART for at least six months, and a comparator group of 110 age‐matched HIV‐uninfected adolescents were tested between August 2013 and April 2015 using echocardiography, six‐minute walk test (6MWT) and spirometry. Those with either abnormal spirometry or abnormal 6MWT and any right or left systolic or diastolic dysfunction or abnormal mean pulmonary arterial pressure were considered as having impaired cardiopulmonary function. Logistic regression was used to investigate determinants of impaired cardiopulmonary function. RESULTS: Overall, 474 adolescents with perinatally acquired HIV (mean [SD] age, 12 [1.6] years; median [IQR] ART duration, 7 [4.6 to 9.3] years; median [IQR] CD4 count, 712 [571 to 959] cell/mm(3)) and 109 HIV‐uninfected adolescents mean (SD) age 11.8 (1.8) years, had successful cardiac and lung function testing. Impaired cardiopulmonary function was detected in 13% of adolescents with perinatally acquired HIV and 8% of HIV‐uninfected adolescents, p = 0.136. Among adolescents with perinatally acquired HIV, those with low tricuspid annular plane systolic excursion (TAPSE) had significantly lower mean FEV(1), 1.5 L versus 1.6 L, p = 0.011. Height (OR 0.7, 95%CI 0.5 to 0.9), body mass index (OR 0.7, 95%CI 0.5 to 0.9) and past pulmonary tuberculosis (OR 2.3, 95%CI 1.2 to 4.4) were significantly associated with a low cardiopulmonary function. CONCLUSIONS: Despite being on ART, cardiopulmonary dysfunction occurs in an appreciable proportion of perinatally HIV‐infected adolescents but no significant difference to uninfected controls. This finding requires further exploration. Factors associated with dysfunction may be amenable to public health interventions to reduce cardiopulmonary disease in this population. John Wiley and Sons Inc. 2019-07-10 /pmc/articles/PMC6619484/ /pubmed/31291058 http://dx.doi.org/10.1002/jia2.25340 Text en © 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Githinji, Leah N
Mahtab, Sana
Zühlke, Liesl
Lawrenson, John
Myer, Landon
Gray, Diane
Zar, Heather
Cardiopulmonary dysfunction in perinatally HIV‐infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort
title Cardiopulmonary dysfunction in perinatally HIV‐infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort
title_full Cardiopulmonary dysfunction in perinatally HIV‐infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort
title_fullStr Cardiopulmonary dysfunction in perinatally HIV‐infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort
title_full_unstemmed Cardiopulmonary dysfunction in perinatally HIV‐infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort
title_short Cardiopulmonary dysfunction in perinatally HIV‐infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort
title_sort cardiopulmonary dysfunction in perinatally hiv‐infected south african adolescents on antiretroviral therapy: baseline findings from the cape town adolescent antiretroviral cohort
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619484/
https://www.ncbi.nlm.nih.gov/pubmed/31291058
http://dx.doi.org/10.1002/jia2.25340
work_keys_str_mv AT githinjileahn cardiopulmonarydysfunctioninperinatallyhivinfectedsouthafricanadolescentsonantiretroviraltherapybaselinefindingsfromthecapetownadolescentantiretroviralcohort
AT mahtabsana cardiopulmonarydysfunctioninperinatallyhivinfectedsouthafricanadolescentsonantiretroviraltherapybaselinefindingsfromthecapetownadolescentantiretroviralcohort
AT zuhlkeliesl cardiopulmonarydysfunctioninperinatallyhivinfectedsouthafricanadolescentsonantiretroviraltherapybaselinefindingsfromthecapetownadolescentantiretroviralcohort
AT lawrensonjohn cardiopulmonarydysfunctioninperinatallyhivinfectedsouthafricanadolescentsonantiretroviraltherapybaselinefindingsfromthecapetownadolescentantiretroviralcohort
AT myerlandon cardiopulmonarydysfunctioninperinatallyhivinfectedsouthafricanadolescentsonantiretroviraltherapybaselinefindingsfromthecapetownadolescentantiretroviralcohort
AT graydiane cardiopulmonarydysfunctioninperinatallyhivinfectedsouthafricanadolescentsonantiretroviraltherapybaselinefindingsfromthecapetownadolescentantiretroviralcohort
AT zarheather cardiopulmonarydysfunctioninperinatallyhivinfectedsouthafricanadolescentsonantiretroviraltherapybaselinefindingsfromthecapetownadolescentantiretroviralcohort